Divi's Laboratories Ltd

1
NSE:DIVISLAB (India)   Ordinary Shares
₹ 3911.50 (+3.11%) May 13
72.80
P/B:
7.94
Market Cap:
₹ 1.04T ($ 12.43B)
Enterprise V:
₹ 1.00T ($ 12.00B)
Volume:
608.33K
Avg Vol (2M):
542.36K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Divi's Laboratories Ltd ( ) from 2003 to May 14 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Divi's Laboratories stock (NSE:DIVISLAB) PE ratio as of May 14 2024 is 72.8. More Details

Divi's Laboratories Ltd (NSE:DIVISLAB) PE Ratio (TTM) Chart

To

Divi's Laboratories Ltd (NSE:DIVISLAB) PE Ratio (TTM) Historical Data

Total 1275
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
Divi's Laboratories PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-14 75.1 2024-03-11 69.2
2024-05-13 75.1 2024-03-08 69.1
2024-05-10 72.8 2024-03-07 69.1
2024-05-09 72.7 2024-03-06 68.0
2024-05-08 75.4 2024-03-05 66.9
2024-05-07 75.1 2024-03-04 66.8
2024-05-06 76.0 2024-03-01 66.8
2024-05-03 75.8 2024-02-29 67.0
2024-05-02 76.1 2024-02-28 67.5
2024-04-30 76.8 2024-02-27 67.9
2024-04-29 76.5 2024-02-26 68.7
2024-04-26 77.1 2024-02-23 70.0
2024-04-25 73.8 2024-02-22 70.0
2024-04-24 73.2 2024-02-21 70.0
2024-04-23 72.3 2024-02-20 71.3
2024-04-22 71.7 2024-02-19 71.5
2024-04-19 70.5 2024-02-16 71.6
2024-04-18 71.2 2024-02-15 71.2
2024-04-17 72.2 2024-02-14 71.4
2024-04-16 72.2 2024-02-13 71.0
2024-04-15 71.3 2024-02-12 71.8
2024-04-12 72.5 2024-02-09 70.1
2024-04-11 71.8 2024-02-08 70.7
2024-04-10 71.8 2024-02-07 71.6
2024-04-09 73.0 2024-02-06 71.5
2024-04-08 72.8 2024-02-05 71.0
2024-04-05 71.9 2024-02-02 71.0
2024-04-04 71.7 2024-02-01 70.2
2024-04-03 70.7 2024-01-31 70.4
2024-04-02 69.5 2024-01-30 68.2
2024-04-01 68.5 2024-01-29 68.5
2024-03-29 66.1 2024-01-26 68.7
2024-03-28 66.1 2024-01-25 68.7
2024-03-27 64.6 2024-01-24 69.9
2024-03-26 65.1 2024-01-23 69.4
2024-03-25 65.8 2024-01-22 70.9
2024-03-22 65.8 2024-01-19 70.9
2024-03-21 66.5 2024-01-18 71.0
2024-03-20 65.8 2024-01-17 71.6
2024-03-19 66.2 2024-01-16 73.2
2024-03-18 67.3 2024-01-15 75.0
2024-03-15 66.9 2024-01-12 74.5
2024-03-14 67.5 2024-01-11 74.9
2024-03-13 66.8 2024-01-10 74.9
2024-03-12 68.7 2024-01-09 76.5

Divi's Laboratories Ltd (NSE:DIVISLAB) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. Most of the company's sales are generated in Europe, followed by North America, India, and Asia. The company has three distinct business segments: Generic APIs, Custom Synthesis, and Nutraceuticals. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.